N/A
Completed N=156
Use of Intra-aortic Balloon Pump Before Surgery for Acute Myocardial Infarction
Myocardial Infarction · Coronary Artery Disease · Coronary Bypass Graft Stenosis of Autologous Vessel · Troponin
Source: ClinicalTrials.gov NCT06468982 ↗
Enrolled (actual)
156
Serious AEs
16.0%
Results posted
Feb 2025
Primary outcomePrimary: High-Sensitivity Cardiac Troponin Levels From Days 0-7 — 29.2; 17.3; 23.2; 16.7 ng/mL (0-0.04) — p=0.05
Summary
The optimal timing of surgery in patients with acute myocardial infarction (AMI) and the utilization of preoperative intra-aortic balloon pumps (IABP) in these patients are subjects of ongoing discussion and disagreement. This study aimed to investigate the effects of preoperative IABP on troponin levels, surgical timing, and intraoperative and postoperative outcomes for patients with AMI who undergo coronary artery bypass grafting (CABG).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY High-Sensitivity Cardiac Troponin Levels From Days 0-7 |
29.2; 17.3; 23.2; 16.7; 15.8; 14.9 | 0.05 |
| SECONDARY In-hospital Mortality |
4; 7 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- Patients who have had acute myocardial infarction and have been decided on coronary surgical revascularization
Exclusion Criteria
- mechanical complications of Acute Myocardial Infarction (such as a ruptured chordal or ventricular septum)
- peripheral arterial disease
- renal failure
- history of cerebrovascular accident
- acute cardiogenic shock and cardiac arrest
- reoperation and combined operations
Data sourced from ClinicalTrials.gov (NCT06468982). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.